You are using an older browser that does not support current Web standards. Although this site is viewable in all browsers, it will look much better in a browser that supports Web standards.

Pitt HomeFind PeopleContact Us

 

Vascular Medicine Institute

VMI
created on wordle.com

About the VMI

The Vascular Medicine Institute at the University of Pittsburgh (VMI) was founded in 2008 with the support of the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania. It is part of the Department of Medicine in the University of Pittsburgh School of Medicine, and our multidisciplinary team of scientists have appointments in the Division of Pulmonary, Allergy and Critical Care Medicine, the Division of Hematology/Oncology, the Department of Pharmacology & Chemical Biology, and the Department of Pathology.

Mission

  • To perform rigorous, cutting edge basic and translational research in vascular biology, guided by a systems biology view of the vasculature, where blood flow is regulated by the vessel, circulating molecules and blood cells. This research is driven by scientists with expertise in hemostasis, red blood cell biophysics, transfusion medicine, cardiovascular biology, mitochondrial biology and nitrite-nitric oxide-reactive oxygen species biochemistry and signaling.
  • To train the next generation of scientists in bench-to-bedside translational research.

 

Vision

The VMI will harness inter-disciplinary teams of researchers in hemostasis, red blood cell biophysics, transfusion medicine, cardiovascular biology, mitochondrial biology and nitrite-nitric oxide and reactive oxygen species biochemistry to expand our understanding of the control of blood flow to organ systems and the development of novel therapies for diseases such as pulmonary hypertension, sickle cell vasculopathy, atherosclerosis, hypertension and heart disease.

Goals

1) Determine the molecular mechanisms underlying clinically important biomedical problems of hemostasis, thrombosis, transfusion medicine and vascular biology.

2) Develop novel, rationally designed therapies targeting diseases of hemostasis, thrombosis, transfusion medicine and vascular biology to improve the quality of life for patients affected by related disorders.

3) Foster the development of a multidisciplinary training environment for graduate and medical students, residents, clinical and postdoctoral fellows , with an emphasis on hemostasis, thrombosis, transfusion medicine, and vascular biology.

4) Enhance the reputation and recognition of ITxM and HCWP regionally and nationally as active participants in laboratory-based basic and translational research.

The VMI will use three mains strategies to achieve its goals:

Multidisciplinary approach: Bring together experts in translational human subjects research, physiology, biochemistry, molecular biology, pharmacology and biophysics.

Translational Research: Define mechanisms of disease, identify novel molecular and biochemical therapeutic targets, establish phase 0, I and II drug development programs, create new intellectual property.

Training: Develop and define a novel training program in translational medicine in the areas of vascular biology, hematology, cardiology and pulmonary medicine. 

Research Expenditures

This graph demonstrates the growth of VMI expenditures since its inception in 2008.

VMI Research Expenditures

 

 

ITxM
ITXM ITxM
HCWO
HCWP
Top
VMI